FDA Commissioner Marty Makary expressed hopes that 2026 will see the end of unlawful mass compounding of GLP-1s, underscoring the agency's commitment to a stricter regulatory environment
This makes the tablet form Wegovy the first oral GLP-1 approved for weight loss on the market, spurring a new wave of marketing from the manufacturers
Mycotoxins such as ochratoxin, gliotoxin, and trichothecenes are known to: Disrupt lipid membranes Induce oxidative stress Alter immune signaling Affect central nervous system function In this case, both toxin burden and immune sensitization appeared to contribute to disease expression
This listing is presented as a research-use-only reference compound with batch-specific analytical documentation
Increasing folic acid through a healthy diet and taking natural supplements should not cause weight gain
The Phase 2 program covered obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (PMID 37366315, PMID 37385280, PMID 38858523)